| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68c213ba9952360f439567152e047b18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db628fbc812ea146bb6eb24a8c0ab43a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
| filingDate |
2003-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9c54ee98dbaa7f4c1ad18c7c38dc058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29f65249e6eca7a427f71e81a6642421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_430d792f56ee20f2d7fba32ef85771e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08afad16723b3b43f6a9c1e8efc7a3ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f2b2cb372e6a7273e1c84e7986740c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f49170f8eb45c0e36f2b16092dd1542 |
| publicationDate |
2005-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1499339-A1 |
| titleOfInvention |
Anti-inflammatory and wound healing effects of lymphoid thymosin beta 4 |
| abstract |
The invention relates to a method of treating inflammatory conditions in a subject comprising administering to a subject a composition comprising a lymphoid thymosin-β4 polypeptide or a functional lymphoid thymosin-β4 polypeptide variant. The invention also provides a method of promoting wound healing in a subject comprising administering to the subject a composition comprising a lymphoid thymosin-β4 polypeptide or a functional lymphoid thymosin-β4 polypeptide variant. The invention also relates to methods of treating the above mentioned conditions in a subject comprising administering to the subject a nucleic acid encoding a lymphoid thymosin-β4 polypeptide or a functional lymphoid thymosin-β4 polypeptide variant. The invention also relates to pharmaceutical compositions comprising a lymphoid thymosin-β4 polypeptide or a functional lymphoid thymosin-β4 polypeptide variant, or salt thereof, and a pharmaceutically acceptable carrier. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11098093-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10988517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11643447-B2 |
| priorityDate |
2002-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |